CervoMed, Inc. is a clinical stage biotechnology company. It engages in the business of advancing CNS focused therapeutics to benefit patients with a range of degenerative diseases of the brain. The company is currently developing neflamapimod, an investigational orally administered small molecule brain penetrant that inhibits p38MAP kinase alpha. The company was founded in1995 and is headquartered in Boston, MA.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
8
Frequently Asked Questions
What is Market Cap of Diffusion Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Diffusion Pharmaceuticals Inc market cap is $146.98M.
What is the 52-week high for Diffusion Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Diffusion Pharmaceuticals Inc 52 week high is $26.38 as of September 13, 2025.
What is the 52-week low for Diffusion Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Diffusion Pharmaceuticals Inc 52 week low is $4.14 as of September 13, 2025.
What is Diffusion Pharmaceuticals Inc stock price today?
Diffusion Pharmaceuticals Inc stock price today is $24.20.
What was Diffusion Pharmaceuticals Inc stock price yesterday?
Diffusion Pharmaceuticals Inc stock price yesterday was $23.82.
What is the PE ratio of Diffusion Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Diffusion Pharmaceuticals Inc’s P/E ratio is -4.20.
What is the Price-to-Book ratio of Diffusion Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Diffusion Pharmaceuticals Inc P/B ratio is 18.3234.
What is Diffusion Pharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Diffusion Pharmaceuticals Inc's EBITDA is -3.03.
What is the 50-day moving average of Diffusion Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Diffusion Pharmaceuticals Inc 50-day moving average is $19.84.
How many employess does Diffusion Pharmaceuticals Inc has?
